Cardiovascular diseases (CVD), especially those of atherosclerotic origin, are the leading cause of death worldwide . Although CVD commonly manifest in adulthood, risk factors and behaviors begin in childhood and adolescence, and early control delays the progression of the disease . Among these factors, obesity is of particular interest because of its high prevalence, now increasingly affecting more individuals in their early years . In the last few decades, there has been an increase in its prevalence, almost doubling since 1980, and becoming an important public health issue , mainly in developing countries .
In addition to being highly prevalent, obesity is associated with several chronic comorbidities that also increase cardiovascular risk by inducing lipid changes. Even in adolescents, there is a direct relationship between increased body mass index (BMI) and the appearance of lipid changes. A study with American adolescents found the prevalence of lipid alterations was 20.3%, reaching 42.9% in those who were obese . The usual pattern of obesity-associated dyslipidemia is characterized by elevated triglycerides (TG) and low levels of high-density lipoprotein cholesterol (HDL-C), which results in an elevation of non-HDL cholesterol (nHDL-C). This pattern, called ‘combined dyslipidemia’ or ‘atherogenic dyslipidemia’, has been observed in more than 40% of obese American adolescents . It is associated with pathological changes in atherosclerosis and vascular dysfunction in adolescence and young adults and predicts early cardiovascular events in adult life . On the other hand, obesity is not necessarily associated with increased low-density lipoprotein cholesterol (LDLc) . In adolescence, significant elevations of LDLc are infrequent  and, when they occur, they may be associated with familial hypercholesterolemia (FH) .
The development of public policies aimed to improve cardiovascular health in developing countries depends on understanding the updated scenario of risk factor prevalence. Since primordial and primary prevention targets younger ages, the ERICA study was designed to assess the prevalence of the main cardiovascular risk factors in Brazilian adolescents aged 12–17 years . This was a pioneer study in a large and nationally representative sample. We have previously described the prevalence of dyslipidemias in different regions of Brazil  but not how various lipid abnormalities can coexist, and their association with nutritional status, which is the aim of this study.
This study was conducted as part of the ERICA Study, a nationwide, school-based, cross-sectional study conducted in 2013–2014 that evaluated the prevalence of diabetes mellitus, obesity, hypertension, lipid abnormalities, insulin resistance, and inflammatory markers in adolescents aged 12–17 years who attended school in cities with >100,000 inhabitants in Brazil [11, 12].
The sample had been stratified (27 capital cities and five strata composed of cities with >100,000 inhabitants from each of the five country regions) and conglomerated (by school and grade level) at the sample selection stage. Sample weight was calculated using the product of inverse inclusion probabilities in each sampling stage and was calibrated by considering the projected number of adolescents enrolled in schools located in the geographical strata, on December 31, 2013. A pre-stratification estimator was used for modifying the natural weight of the design through a calibration factor that corresponded to the ratio of the total population to the total estimate by using the natural post-stratification weight or estimated domain of the design, more details on the sample design can be found in Vasconcellos et al. .
All the students were interviewed and then submitted a consent form signed by them and their parents/guardians. The following exclusion criteria were applied: students not aged 12–17 years, pregnant adolescents, and individuals with mental or physical disabilities that could prevent evaluations and anthropometric measurements.
A standardized research protocol was adopted for blood collection and used in 27 centers (27 states) . All the participating laboratories received the protocol documentation for all the steps, from scheduling to transportation to the central unit. The adolescents were instructed to fast for 12 hours before sample collection and completed a questionnaire for compliance confirmation. A single reference laboratory (central unit) was used for all the biochemical analyses: triglycerides (TG), HDL-C, glucose, glycated hemoglobin, fasting insulin, and total count levels were evaluated . The LDLc level was calculated using the Friedewald equation .
In this analysis, we evaluated the combination of lipid changes: LDLc ≥ 100 mg/dL, HDL-C < 45 mg/dL, and TG ≥ 100 mg/dL.
Adolescents healthy into eight groups: profile 1, adolescents with normal lipid profile variables; profiles 2, 3 and 4, those with only one altered variable; profiles 5, 6 and 7, those with two altered variables; and profile 8, participants with all variables of the lipid profile altered. The prevalence of each profile was estimated for each category of nutritional status.
Adolescents with a BMI z-score for their sex and age group that was ≤–2 were considered to have very low or low weight; those with z-scores between >–2 and <+1 were considered to have an appropriate weight; when the z-score was ≥+1 and <+2, they were classified as being overweight; and with a z-score ≥+2 they were obese .
Prevalence and 95% confidence interval (CI) were calculated for each lipid according to sex, age, school category, countrywide, and region. Mean values were estimated for quantitative variables, and proportions were calculated for qualitative variables. A 95% CI was adopted for both cases.
Characteristics of the study population were adjusted according to the sample design, using statistical routines for complex samples. For comparison of ages, the Poisson model was used to calculate the prevalence rate ratio (PRR) using 12 years of age as reference. Analyses were performed by using Stata 14.0v software.
The study was approved by the research ethics committees of the Central Institute for Research Coordination (IESC/UFRJ) and the Pontifical Catholic University of the State of Paraná (PUCPR).
Data were analyzed from 38,069 adolescents who answered the questionnaire and had laboratory parameters of interest. About two-thirds were female, and most of them were in public schools (Table 1). A separate analysis of each lipid profile variable was previously published .
|Gender and age|
|Male, 12–14 years||7,140||18.8|
|Male, 15–17 years||8,107||21.3|
|Female, 12–14 years||10,294||27.0|
|Female, 15–17 years||12,528||32.9|
More than 24,000 adolescents presented at least one altered lipid profile variable (64.7%), and 3.7% presented alterations in all variables (Figure 1).
The most commonly found lipid combinations were high TG and low HDL, and adolescents with this combination of lipid abnormalities had a greater mean of BMI-Z score (Table 2).
Desirable < 100
Borderline/high ≥ 100
Desirable < 100
Borderline/high ≥ 100
Desirable ≥ 45
|%||BMI z-score (mean, 95%)|
There was an association between the nutritional status and the number of lipid changes found: the higher the BMI, the more altered lipid parameters were found (Graph 1).
The contribution of developing countries to the global burden of cardiovascular diseases is significantly higher than that of the most developed countries . The lack of awareness of lipid abnormalities and their associated factors is a barrier for achieving cardiovascular risk reduction . In this study, we demonstrated that almost 65% of Brazilian adolescents have at least one lipid parameter deviating from the desirable range. Moreover, the number of lipid abnormalities increases together with an increase in BMI.
The recognition of risk factors in children and youth is critical for the development of prevention strategies. The excess of weight in the early years of life is predictive of a worse cardiovascular profile in adulthood. In the Bogalusa Heart Study, 2617 children and adolescents at ages 2 to 17 years were evaluated and lately were reexamined at ages 18 to 37 years (mean follow-up 17 years). In those with a BMI above the 95th percentile, 77% remained obese in adulthood, and this obesity was associated with abnormalities in lipids, blood pressure and insulin levels . These findings reinforce the need for primordial and primary prevention.
Combined evidence from autopsy studies and cohort studies strongly indicate that abnormal lipid levels in childhood are associated with increased atherosclerosis . Atherosclerosis, therefore, begins in youth and is related, from its earliest stages to the presence and intensity of known cardiovascular risk factors, such as family history, age, gender, diet, sedentary lifestyle, smoking, hypertension, dyslipidemia, overweight and obesity, diabetes and metabolic syndrome. Early identification and control of dyslipidemia throughout youth substantially reduces the risk of CVD in early adulthood. In a 25-year follow-up, the presence of risk factors of metabolic syndrome in childhood was associated with clinical CVD in adults between 30 and 48 years of age .
In our study, the majority of adolescents presented at least one altered variable of the lipid profile, which is in agreement with data reported in other populations. In 2011 and 2012, approximately 1 in 5 North American children and adolescents aged 8–17 years had adverse levels of the lipid parameters, total cholesterol, HDL-C, or non-HDL-C .
Among adolescents with two altered lipid variables, the altered variables most commonly associated with a high BMI z-score were high TG and low HDL-C. The Princeton Follow-up Study found that high TG and TG/HDL-C ratio for an average age of 12 years were predictors of cardiovascular disease 30–40 years later. It has been demonstrated that the TG/HDL-C ratio is the strongest predictor of the extent of coronary disease in adults, and is considered an alternative atherogenicity index of the plasma lipid profile .
It is also known that high BMI is related to risk factors and cardiovascular morbidity. In the United States, the Centers for Disease Control and Prevention reviewed the results of the National Health and Nutrition Examination Survey (NHANES) from 1999–2006. Of all the participants, 32% had a high BMI and were candidates for lipid screening under recommendations of the American Pediatric Association. There was a high prevalence of abnormal lipid levels among children and adolescent who were overweight (22.3%) or obese (42.9%) , as we have also demonstrated in our study.
The optimal way to screen for dyslipidemia in children and adolescents is not known. The recommendation from the National Cholesterol Education Program (NCEP) of the National Heart, Lung, and Blood Institute is that screening be made in children with a family history of early cardiovascular disease or high cholesterol. They also recommend screening for other risk factors in children with obesity, hypertension, and diabetes mellitus . The United States Preventive Services Task Force stated in 2016 that there is insufficient evidence to assess the effect of screening for dyslipidemia in adolescents . However, our study suggests that elevated BMI alone can be indicative of the need for dyslipidemia screening.
These results can be used not only to guide adolescents and parents about preventive measures but also to support the development of effective public health policies for the prevention and control of risk factors for diabetes and cardiovascular diseases in adolescents .
Strategies described to change this scenario among adolescents include lifestyle interventions , combined approaches to diet and physical activity for weight loss ; pharmaceutical treatment is rarely required , but always after an attempt of lifestyle changes . Furthermore, some multidisciplinary pediatric programs seem to be more successful than programs for adults in maintaining weight loss for 5 or 10 years . Recently the Familia study demonstrated that a four-month educational program with a multicomponent intervention promoting a healthy diet, increasing physical activity, understanding the human body, and managing emotions is an effective strategy to change behavior in children . In Brazil, the Children First Study demonstrated that an educational program in cardiovascular prevention aimed at children aged 6 to 10 years can reduce the Framigham cardiovascular risk of their parents .
A comprehensive primary health care strategy that includes primary and secondary prevention and care and follow-up of cardiovascular diseases is associated with the reduction of morbidity and mortality due to cardiovascular diseases in Brazil , both in childhood and adulthood.
According to the World Health Organization, governments, the private sector, and civil society can work together to implement interventions on this issue. If they do, the overall goal for chronic disease prevention and control will be met, and millions of lives may be saved .
Abnormal BMI of overweight/obesity in Brazilian adolescents directly reflects the alteration of the lipid profile.
We have also shown that the most common association between two altered lipid variables is that of TG and HDL-C together, representing a possible risk to Brazilian adolescents.
From this study, the use of BMI can be considered as an indicator of the diagnosis of dyslipidemia in adolescents, aiming at early interventions in the Brazilian lifestyle and consequent reduction of morbidity and mortality.
ERICA was funding by the Ministry of Health (Science and Technology Department) and the Ministry of Science and Technology (Funding Authority for Studies and Projects [FINEP] and the National Council for Scientific and Technological Development [CNPq]; Protocols: FINEP 01090421; CNPq 565037/2010-2 and 405.009/2012-7).
The authors have no competing interests to declare.
World Health Organization. Preventing Chronic Diseases – A Vital Investment. WHO; 2005.
Daniels SR, Greer FR. Lipid screening and cardiovascular health in childhood. Pediatrics. 2008; 122(1): 198–208. DOI: https://doi.org/10.1542/peds.2008-1349
Bloch KV, Klein CH, Szklo M, Kuschnir MC, Abreu Gde A, Barufaldi LA, et al. ERICA: Prevalences of hypertension and obesity in Brazilian adolescents. Rev Saude Publica. 2016; 50(Suppl 1): 9s.
Pi-Sunyer FX. The obesity epidemic: Pathophysiology and consequences of obesity. Obesity research. 2002; 10(Suppl 2): 97S–104S. DOI: https://doi.org/10.1038/oby.2002.202
Poobalan A, Aucott L. Obesity among young adults in developing countries: A systematic overview. Curr Obes Rep. 2016; 5(1): 2–13. DOI: https://doi.org/10.1007/s13679-016-0187-x
Prevalence of abnormal lipid levels among youths – United States, 1999–2006. MMWR Morbidity and mortality weekly report. 2010; 59(2): 29–33.
Kavey RE. Combined dyslipidemia in childhood. Journal of Clinical Lipidology. 2015; 9(5 Suppl): S41–56. DOI: https://doi.org/10.1016/j.jacl.2015.06.008
Expert Panel on Integrated Guidelines for Cardiovascular H, Risk Reduction in C, Adolescents, National Heart L, Blood I. Expert panel on integrated guidelines for cardiovascular health and risk reduction in children and adolescents: Summary report. Pediatrics. 2011; 128(Suppl 5): S213–56. DOI: https://doi.org/10.1542/peds.2009-2107C
Kaestner TL, Bento VF, Pazin DC, Baena CP, Olandoski M, Abreu GA, et al. Prevalence of high cholesterol levels suggestive of familial hypercholesterolemia in Brazilian adolescents: Data from the study of cardiovascular risk in adolescents. Journal of Clinical Lipidology. 2018; 12(2): 403–8. DOI: https://doi.org/10.1016/j.jacl.2017.12.009
Goldberg AC, Hopkins PN, Toth PP, Ballantyne CM, Rader DJ, Robinson JG, et al. Familial hypercholesterolemia: Screening, diagnosis and management of pediatric and adult patients: Clinical guidance from the National Lipid Association Expert Panel on Familial Hypercholesterolemia. Journal of clinical lipidology. 2011; 5(3 Suppl): S1–8.
Bloch KV, Szklo M, Kuschnir MCC, de Azevedo Abreu G, Barufaldi LA, Klein CH, et al. The Study of Cardiovascular Risk in Adolescents–ERICA: Rationale, design and sample characteristics of a national survey examining cardiovascular risk factor profile in Brazilian adolescents. BMC Public Health. 2015; 15(1): 1.
Faria Neto JR, Bento VF, Baena CP, Olandoski M, Goncalves LG, Abreu Gde A, et al. ERICA: Prevalence of dyslipidemia in Brazilian adolescents. Rev Saude Publica. 2016; 50(Suppl 1): 10s. DOI: https://doi.org/10.1590/s01518-8787.2016050006723
Vasconcellos MT, Silva PL, Szklo M, Kuschnir MC, Klein CH, Abreu Gde A, et al. Sampling design for the Study of Cardiovascular Risks in Adolescents (ERICA). Cadernos de saude publica. 2015; 31(5): 921–30. DOI: https://doi.org/10.1590/0102-311X00043214
Cureau FV, Bloch KV, Henz A, Schaan CW, Klein CH, Oliveira CL, et al. Challenges for conducting blood collection and biochemical analysis in a large multicenter school-based study with adolescents: Lessons from ERICA in Brazil. Cadernos de saude publica. 2017; 33(4): e00122816. DOI: https://doi.org/10.1590/0102-311x00122816
Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clinical chemistry. 1972; 18(6): 499–502. DOI: https://doi.org/10.1093/clinchem/18.6.499
Cole TJ, Bellizzi MC, Flegal KM, Dietz WH. Establishing a standard definition for child overweight and obesity worldwide: International survey. BMJ. 2000; 320(7244): 1240–3. DOI: https://doi.org/10.1136/bmj.320.7244.1240
Roth GA, Forouzanfar MH, Moran AE, Barber R, Nguyen G, Feigin VL, et al. Demographic and Epidemiologic Drivers of Global Cardiovascular Mortality. New England Journal of Medicine. 2015; 372(14): 1333–41. DOI: https://doi.org/10.1056/NEJMoa1406656
Murphy A, Faria-Neto JR, Al-Rasadi K, Blom D, Catapano A, Cuevas A, et al. World Heart Federation Cholesterol Roadmap. Global Heart. 2017; 12(3): 179–97.e5. DOI: https://doi.org/10.1016/j.gheart.2017.03.002
Freedman DS, Khan LK, Dietz WH, Srinivasan SR, Berenson GS. Relationship of childhood obesity to coronary heart disease risk factors in adulthood: The Bogalusa Heart Study. Pediatrics. 2001; 108. DOI: https://doi.org/10.1542/peds.108.3.712
Kit BK, Kuklina E, Carroll MD, Ostchega Y, Freedman DS, Ogden CL. Prevalence of and trends in dyslipidemia and blood pressure among US children and adolescents, 1999–2012. JAMA Pediatrics. 2015; 169(3): 272–9. DOI: https://doi.org/10.1001/jamapediatrics.2014.3216
da Luz PL, Favarato D, Faria-Neto JR, Jr., Lemos P, Chagas AC. High ratio of triglycerides to HDL-cholesterol predicts extensive coronary disease. Clinics (Sao Paulo). 2008; 63(4): 427–32. DOI: https://doi.org/10.1590/S1807-59322008000400003
Force USPST. Screening for lipid disorders in children and adolescents: US preventive services task force recommendation statement. JAMA. 2016; 316(6): 625–33. DOI: https://doi.org/10.1001/jama.2016.9852
Nemet D, Barkan S, Epstein Y, Friedland O, Kowen G, Eliakim A. Short- and long-term beneficial effects of a combined dietary-behavioral-physical activity intervention for the treatment of childhood obesity. Pediatrics. 2005; 115(4): e443–9. DOI: https://doi.org/10.1542/peds.2004-2172
Ford ES, Li C, Zhao G, Mokdad AH. Concentrations of low-density lipoprotein cholesterol and total cholesterol among children and adolescents in the United States. Circulation. 2009; 119(8): 1108–15. DOI: https://doi.org/10.1161/CIRCULATIONAHA.108.816769
Fernandez-Jimenez R, Jaslow R, Bansilal S, Santana M, Diaz-Munoz R, Latina J, et al. Child Health Promotion in Underserved Communities: The FAMILIA Trial. J Am Coll Cardiol. 2019; 73(16): 2011–21. DOI: https://doi.org/10.1016/j.jacc.2019.01.057
Fornari LS, Giuliano I, Azevedo F, Pastana A, Vieira C, Caramelli B. Children First Study: How an educational program in cardiovascular prevention at school can improve parents’ cardiovascular risk. Eur J Prev Cardiol. 2013; 20(2): 301–9. DOI: https://doi.org/10.1177/2047487312437617
Rasella D, Harhay MO, Pamponet ML, Aquino R, Barreto ML. Impact of primary health care on mortality from heart and cerebrovascular diseases in Brazil: A nationwide analysis of longitudinal data. BMJ. 2014; 349: g4014. DOI: https://doi.org/10.1136/bmj.g4014